Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Determinants of treatment outcomes of multidrug-resistant tuberculosis: an Individual Patient Data Meta-Analysis
FY 2016-17
Summary
Multidrug-resistant tuberculosis (MDR-TB) has become a major threat to global tuberculosis control in recent years. MDR-TB infection is associated with lengthy treatment duration, use of toxic drugs, and generally poor outcomes. In the past six years, newer drugs and regimens have been used to treat MDR-TB, but there is very little good evidence to guide current MDR-TB therapy.Between August and November 2015, I worked on a systematic review that identified 74 studies, published since 2009, that reported MDR-TB treatment regimens and outcomes. Since January 2016, I have been working on an individual patient data (IPD) meta-analysis to determine optimal treatment for MDR-TB. As a first step, I invited authors of the 74 studies to participate in this IPD study. A total of 50 TB research groups agreed to share their data. I am now assembling all datasets into one database, with detailed clinical and treatment information for 12,245 MDR-TB patients.For my MSc thesis, I will analyze this data using appropriate meta-analytical methods. Objectives of the analysis include identifying determinants of treatment outcomes: efficacy of specific drugs, such as later-generation fluoroquinolones, linezolid and bedaquiline; adverse events associated with individual drugs; and the optimal number of drugs and duration of MDR-TB therapy.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
367177
Name
Lan Zhiyi
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Determinants of treatment outcomes of multidrug-resistant tuberculosis: an Individual Patient Data Meta-Analysis
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adverse Event; Drug Efficacy; Drug Resistance; Drug Safety; Individual Patient Data Meta-Analysis; Systematic Review; Treatment Regimen; Tuberculosis
Abstract
Multidrug-resistant tuberculosis (MDR-TB) has become a major threat to global tuberculosis control in recent years. MDR-TB infection is associated with lengthy treatment duration, use of toxic drugs, and generally poor outcomes. In the past six years, newer drugs and regimens have been used to treat MDR-TB, but there is very little good evidence to guide current MDR-TB therapy.Between August and November 2015, I worked on a systematic review that identified 74 studies, published since 2009, that reported MDR-TB treatment regimens and outcomes. Since January 2016, I have been working on an individual patient data (IPD) meta-analysis to determine optimal treatment for MDR-TB. As a first step, I invited authors of the 74 studies to participate in this IPD study. A total of 50 TB research groups agreed to share their data. I am now assembling all datasets into one database, with detailed clinical and treatment information for 12,245 MDR-TB patients.For my MSc thesis, I will analyze this data using appropriate meta-analytical methods. Objectives of the analysis include identifying determinants of treatment outcomes: efficacy of specific drugs, such as later-generation fluoroquinolones, linezolid and bedaquiline; adverse events associated with individual drugs; and the optimal number of drugs and duration of MDR-TB therapy.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lan, Zhiyi
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~